Biscornet 2017.
Study characteristics | |||
Patient sampling | Cross‐sectional study with consecutive sampling method. | ||
Patient characteristics and setting | Sample size: 31 cases, 192 non‐cases (total 223) Clinical presentation: acute fever of unknown origin > 3 days, with or without any of the following: headaches, myalgia, haemorrhagic manifestations in the absence of any definite diagnosis. Risk factors: NR Region: Seychelles, nationwide Clinical setting: population‐based national survey Prevalence of leptospirosis: 13.9% DPO of disease at moment of enrolment: NR |
||
Index tests |
Index test: real‐time PCR (TaqMan) Target gene: rrs (Smythe 2002) Timing of sample collection at # DPO of disease: NR Cut‐off value: 35 Ct Patient material: serum Company/brand: inhouse Frozen samples: yes |
||
Target condition and reference standard(s) | Target condition: leptospirosis Case definition: MAT or IgM ELISA positive, or both Timing of sample collection at # DPO of disease (MAT): acute: NR; convalescent: ≥ 4 weeks DPO Single or paired sera (MAT): single and paired Cut‐off value (MAT): 1:400 or 4‐fold titre rise Patient material (MAT): serum Timing of sample collection at # DPO of disease (IgM ELISA): acute: NR; convalescent: ≥ 4 weeks DPO Single or paired sera (IgM ELISA): NR Cut‐off value (IgM ELISA): NR Patient material (IgM ELISA): serum |
||
Flow and timing | All people were included in the analysis. | ||
Comparative | |||
Notes | |||
Methodological quality | |||
Item | Authors' judgement | Risk of bias | Applicability concerns |
DOMAIN 1: Patient Selection | |||
Was a consecutive or random sample of patients enrolled? | Yes | ||
Was a 2‐gate case‐control design avoided? | Yes | ||
Did the study avoid inappropriate exclusions? | Yes | ||
Low | Low | ||
DOMAIN 2: Index Test Real‐time PCR | |||
Were the index test results interpreted without knowledge of the results of the reference standard? | Unclear | ||
If a threshold was used, was it pre‐specified? | Yes | ||
Does the index test, its conduct and interpretation, match the review question? | No | ||
Is the execution of the test reported in such detail that reproduction is possible? | Yes | ||
Unclear | High | ||
DOMAIN 3: Reference Standard | |||
Is this the type of test that is likely to correctly classify the target condition? | Yes | ||
Did the execution of the MAT include paired samples? | Yes | ||
Were the reference standard results interpreted without knowledge of the results of the index tests? | Unclear | ||
Does the case definition match the review question? | Yes | ||
Is the execution of the test reported in such detail that reproduction is possible? | Yes | ||
Unclear | Low | ||
DOMAIN 4: Flow and Timing | |||
Was there an appropriate interval between index test and reference standard? | Unclear | ||
Did all patients receive a reference standard? | Yes | ||
Did all patients receive the same reference standard? | Yes | ||
Were all patients included in the analysis? | Yes | ||
Low |